BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Accugenix Inc. Parters With AgenoLab For Greater Convenience for Microbial Identification Services


3/23/2010 1:24:44 PM

Newark, DE – March 15, 2010. Accugenix announces a new strategic partnership with Agenolab GmbH & Co.KG to provide pharmaceutical, biotechnology, medical device and other manufacturing industries with local access and convenience to the Company’s expertise in microbial identification services. For over 20 years, Accugenix has tested more microorganisms than any other company or service laboratory in world, which has allowed the company to develop and refine a validated proprietary organism library and method of interpretation unrivaled in the industry. Now, European organizations can directly benefit from these world-class capabilities with the convenience of working with a local laboratory. Agenolab provides both genotypic and proteotypic sample analysis in their Stuttgart facility in Germany, and is electronically linked to Accugenix’s Newark, Delaware facility in the US where data analysis, interpretation and result reporting is conducted.

“The presence of a European lab enables our customers to benefit from the same level of service in accuracy, reliability and convenience that our US customers have enjoyed for years”, according to Doug Smith, Chief Executive Officer of Accugenix. “We were delighted to find a partner so appropriately suited to expand our presence in Europe and uphold our commitment to the highest of cGMP and EU GMP.”

Agenolab GmbH & Co.KG is an innovative biotechnology & life science laboratory. Founded in 2007, Agenolab is continuously growing and expanding its collaborations, implementing state-of-the art technologies, using the most advanced equipment and maintaining a continuously trained, highly motivated staff and “Gold Standard” services.

About Accugenix

For over 20 years, Accugenix has been the world’s leading FDA-registered, cGMP service laboratory for microbial identification and characterization. More than 1000 facilities around the world rely on the company’s expertise to meet their microbial identification needs.


Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES